Tazarotene gel: Efficacy and safety in plaque psoriasis

Journal of the American Academy of Dermatology

Volumn 37, Issue 2 III SUPPL., 1997, Pages

  Weinstein, G D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUMETASONE ACETATE; TAZAROTENE;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; HUMAN; PRIORITY JOURNAL; PSORIASIS;

EID: 0030750232     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(97)80398-2     Document Type: Conference Paper

References (19)

1. A Menter JNWN Barker Psoriasis in practice Lancet 338 1991 213 234
2. GG Krueger M Duvic Epidemiology of psoriasis: clinical issues J Invest Dermatol 102 1994 14S 18S
3. GD Weinstein JL McCullough PA Ross Cell kinetic basis for pathophysiology of psoriasis J Invest Dermatol 85 1985 579 583
4. GG Krueger A perspective of psoriasis as an aberration in skin modified to expression by the inflammatory/repair system Immune mechanisms in cutaneous disease 1989 Marcel Dekker New York 425 455
5. SL Gottlieb P Gilleaudeau R Johnson Response of psoriasis to a lymphocyte-selective toxin (DAB389-IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis Nature Medicine 1 1995 442 447
6. GD Weinstein JG Krueger An overview of psoriasis GD Weinstein AB Gottlieb Therapy of moderate-to-severe psoriasis 1993 National Psoriasis Foundation Portland 2 22
7. MW Greaves GD Weinstein Treatment of psoriasis N Engl J Med 337 1995 581 588
8. WH Liem JL McCullough GD Weinstein Effectiveness of topical therapy for psoriasis: results of a national survey Cutis 55 1995 306 310
9. P Frost GD Weinstein Topical administration of vitamin A acid for ichthyosiform dermatoses and psoriasis JAMA 207 1969 1863 1868
10. CE Orfanos HW Schmidt G Mahrle Retinoic acid in psoriasis: its value for topical therapy with and without corticosteroids. Clinical, histological and electron microscopical studies on forty-four hospitalized patients with extensive psoriasis Br J Dermatol 88 1973 167 182
11. A MacDonald MH McMinn L Fry Effect of retinoic acid in psoriasis, II. Long term study Br J Dermatol 87 1972 256 260
12. S Günther The therapeutic value of retinoic acid in chronic discoid, acute guttate, and erythrodermic psoriasis: clinical observations on twenty-five patients Br J Dermatol 89 1973 515 517
13. T Fredriksson Antipsoriatic activity of retinoic acid (vitamin A acid) Dermatologica 142 1971 133 136
14. R Bischoff EMGJ De Jong HFC Rulo Topical application of 13- cis -retinoic acid in the treatment of chronic plaque psoriasis Clin Exp Dermatol 17 1992 9 12
15. T Esgleyes-Ribot RA Chandraratna DA Lew-Kaya Response of psoriasis to a new topical retinoid, AGN 190168 J Am Acad Dermatol 30 1994 581 590
16. DA Lew-Kaya J Sefton GG Krueger Safety and efficacy of a new retinoid gel in the treatment of psoriasis (Abstract) J Invest Dermatol 98 1992 600
17. GD Weinstein L Green LA Drake New topical retinoid gel for therapy of psoriasis: dose-ranging study of AGN 190168 (Abstract) J Invest Derm 100 1993 544
18. G Weinstein E Jeffes M Duvic Tazarotene gel for the treatment of plaque psoriasis: a double-blind clinical study [abstract] J Invest Dermatol 104 1995 661
19. The Tazarotene Clinical Study Group Tazarotene 0.1% and 0.05% gels compared with fluocinonide 0.05% cream in the treatment of plaque psoriasis: an investigator-masked study of safety, efficacy, and duration of therapeutic effect [poster] Presented at Clinical Dermatology 2000 International Congress; Vancouver, British Columbia, Canada 1996 May 28-31